Syndrome X
Conditions
Keywords
somatization symptom score, SSS checklist, coronary angiography, Patient Health Questionnaire, Generalized Anxiety Disorder 7-items
Brief summary
A comparative study is conducted on the patients with suspected coronary artery disease (CAD). The patient will undergo coronary angiography after a somatic symptom scale (SSS) survey is carried out combining with Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder 7-items (GAD-7). Patient is then treated according to the checklist score and coronary angiography result. The efficacy, sensitivity and specificity of the SSS checklist will be evaluated during following up.
Detailed description
The presentation of physical complaints such as chest discomfort suggestive of suspicious coronary artery disease (CAD) but remain unexplained after negative finding from coronary angiography represents one of the most frustrating and puzzling problems in clinical medicine.A comparative study is conducted on the patients with suspected coronary artery disease. A somatic symptom scale (SSS) survey is carried out combining with Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder 7-items (GAD-7). Patient is treated according to the checklist score and coronary angiography result. Three surveys will be re-conducted 2 weeks after treatment. The sensitivity and specificity of the SSS checklist will be evaluated during following up.
Interventions
DRUGDeanxit
we use Deanxit for the patient with anxiety
DRUGProzac
we use Prozac for the patient with depression
PROCEDUREcoronary artery disease treatment
including medication, coronary artery stent implantation according to the severity of stenosis of the coronary arteries
Sponsors
RenJi Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* patients with suspected coronary artery disease
Exclusion criteria
* patients who have lost their self assessments of capacity. * patients who have been previously confirmed serious mental disorders. * patients who is taking anti-anxiety agents or anti-depression agents.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The efficacy of somatization symptom score | 2 weeks after the first visit | observe the efficacy by the score of somatic symptom scale (SSS), Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder 7-items (GAD-7) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| scale chest discomfort | 2 weeks after the first visit | observe if the chest discomfort no change, alleviate or disappear |
| The efficacy of Patient Health Questionnaire | 2 weeks after the first visit | observe the efficacy by the score of Patient Health Questionnaire (PHQ-9) |
| The efficacy of Generalized Anxiety Disorder 7-items | 2 weeks after the first visit | observe the efficacy by the score of Generalized Anxiety Disorder 7-items (GAD-7) |
Countries
China
Contacts
Primary ContactMao Jialiang, Docter
Backup ContactJiang Meng, Doctor
Outcome results
None listed